Back to Search
Start Over
Should we introduce early a new biological agent in patients with Inflammatory Bowel Disease after anti-TNF discontinuation due to severe anti-TNF-induced skin lesions? A multicenter cohort study
- Source :
- Journal of Crohn's and Colitis, Journal of Crohn's and Colitis, 2022, 16 (Supplement_1), pp.I502-I502. ⟨10.1093/ecco-jcc/jjab232.684⟩
- Publication Year :
- 2022
- Publisher :
- HAL CCSD, 2022.
-
Abstract
- International audience
Details
- Language :
- English
- ISSN :
- 18739946 and 18764479
- Database :
- OpenAIRE
- Journal :
- Journal of Crohn's and Colitis, Journal of Crohn's and Colitis, 2022, 16 (Supplement_1), pp.I502-I502. ⟨10.1093/ecco-jcc/jjab232.684⟩
- Accession number :
- edsair.dedup.wf.001..e126c034a4da2b20a6b59c077842e3e4
- Full Text :
- https://doi.org/10.1093/ecco-jcc/jjab232.684⟩